More than 2,500 professionals from LATAM enjoyed SOLACI-CACI 2024

Last week, we experienced a new edition of the SOLACI-CACI 2024 Congress, and the result was a complete success. 2,585 professionals from 36 countries gathered at the Hilton Hotel for an event that featured 8 simultaneous rooms, live cases, joint sessions, international guests, academic debates, scientific updates, and much more.

It was a special event because the Latin American Society of Interventional Cardiology celebrated its 30th anniversary. In this context, for the first time, the Dr. José Eduardo Sousa and “SOLACI 30 years” awards were given to outstanding figures in Latin American interventional cardiology.

But that’s not all: for the first time, 30% of the faculty was composed of women. Additionally, we had a total of 645 faculty members, and for the Call For Science, more than 300 abstracts, 81 oral presentations, and 151 e-posters were submitted.

In this regard, it was an extremely successful event, and we can only invite you to continue developing Latin American interventional cardiology at the next SOLACI-SOCIME 2025 Congress, which will take place from August 6 to 8, 2025, at Expo Santa Fé, CDMX, Mexico.

We look forward to seeing you there!

 

Más artículos de este Autor

Check out the best images of the El Salvador 2024 Sessions

Review the highlights of the XLIX SOLACI Regional Sessions held at the Intercontinental Hotel in San Salvador, El Salvador between November 7 and 8,...

The El Salvador 2024 Sessions are coming soon

The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Virtual Event SOLACI-Medtronic | The Visible Heart Lab

We invite you to participate in a new virtual activity organized in collaboration with Medtronic, focused on "The Visible Heart Lab" and dedicated to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Artículos relacionados

Jornadas SOLACIspot_img

Artículos recientes

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....